Indication
Diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma is an aggressive malignancy of the lymphatic system and the most common subtype of non-Hodgkin lymphoma, predominantly affecting older adults. Read more about Diffuse large B-cell lymphoma
242 drugs 143 manufacturers
Drugs that treat it
Common Diffuse large B-cell lymphoma therapies.
CYCLOPHOSPHAMIDE
DEXAMETHASONE
DEXAMETHASONE SODIUM PHOSPHATE
PREDNISONE
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
DEXAMETHASONE SODIUM PHOSPHATE
DEXAMETHASONE SODIUM PHOSPHATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiffuse large B-cell lymphoma is an aggressive malignancy of the lymphatic system and the most common subtype of non-Hodgkin lymphoma, predominantly affecting older adults.
It arises from mature B lymphocytes at various stages of differentiation, most notably classified by cell of origin into germinal center B-cell-like and activated B-cell-like phenotypes.
Pathophysiologically, it is characterized by the diffuse proliferation of abnormally large B cells that obliterate normal lymph node architecture or infiltrate extranodal sites.
Clinically, patients typically present with rapidly enlarging nodal or extranodal masses, which may be accompanied by constitutional B symptoms such as fever, drenching night sweats, and unintentional weight loss.
- nih.gov
Diffuse large B-cell lymphoma is an aggressive malignancy of the lymphatic system and the most common subtype of non-Hodgkin lymphoma, predominantly affecting older adults It arises from mature B lymphocytes at various stages of differentiation, most notably classified by cell of origin into germinal center B-cell-like and activated B-cell-like phenotypes
- lymphoma.org
Diffuse large B-cell lymphoma is an aggressive malignancy of the lymphatic system and the most common subtype of non-Hodgkin lymphoma, predominantly affecting older adults
- nih.gov
It arises from mature B lymphocytes at various stages of differentiation, most notably classified by cell of origin into germinal center B-cell-like and activated B-cell-like phenotypes Pathophysiologically, it is characterized by the diffuse proliferation of abnormally large B cells that obliterate normal lymph node architecture or infiltrate extranodal sites
- cancer.gov
Pathophysiologically, it is characterized by the diffuse proliferation of abnormally large B cells that obliterate normal lymph node architecture or infiltrate extranodal sites
- sobi.com
Clinically, patients typically present with rapidly enlarging nodal or extranodal masses, which may be accompanied by constitutional B symptoms such as fever, drenching night sweats, and unintentional weight loss
- nih.gov
Clinically, patients typically present with rapidly enlarging nodal or extranodal masses, which may be accompanied by constitutional B symptoms such as fever, drenching night sweats, and unintentional weight loss
Personalize your experience
Follow Diffuse large B-cell lymphoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.